Identification of a Prognostic Model Based on Immune Cell Signatures in Clear Cell Renal Cell Carcinoma

Figure 8

Prediction of immunotherapy response in the training cohort. (a) Differences of immune checkpoint genes between high and low ICS score groups. (b–e) Differences of IPS between high and low ICS score groups.

(a)

(b)

(c)

(d)

(e)